Anebulo PharmaceuticalsANEB
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 18 institutions reported holding Anebulo Pharmaceuticals Inc. (ANEB) in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were 22NW, LP ($20.1M), Nantahala Capital Management, LLC ($3.9M) and Mangrove Partners Im, LLC ($3.3M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Anebulo Pharmaceuticals Inc.
- CUSIP
- 034569103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $314K |
| Exits | 1 | $100K |
All 13F filers, Q4 2024 → Q1 2025: 411,256 shares bought and 363,361 shares sold, net +47,895 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| 22NW, LP | 13.49% | No change | 15,467,300 | $20.1M |
| Nantahala Capital Management, LLC | 0.33% | No change | 3,036,325 | $3.9M |
| Mangrove Partners Im, LLC | 0.38% | No change | 2,525,252 | $3.3M |
| Morgan Stanley | 0.00% | Reduce -5.0% | 399,219 | $519K |
| LVW Advisors, LLC | 0.05% | Reduce -44.7% | 349,617 | $455K |
| Geode Capital Management, LLC | 0.00% | Add +124.9% | 205,418 | $267K |
| Vanguard Group Inc. | 0.00% | Add +32.8% | 204,545 | $266K |
| Millennium Management | 0.00% | New | 158,967 | $207K |
| Ikarian Capital, LLC | 0.07% | No change | 157,720 | $205K |
| Goldman Sachs Group Inc. | 0.00% | New | 47,954 | $62K |
| HRT Financial LP | 0.00% | New | 23,162 | $30K |
| Boothbay Fund Management, LLC | 0.00% | No change | 18,836 | $24K |
| Citadel Advisors | 0.00% | New | 11,169 | $15K |
| BlackRock, Inc. | 0.00% | Add +46.7% | 5,763 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +6.4% | 3,538 | $5K |
| Bank of America Corp. | 0.00% | Add +4436.8% | 3,448 | $4K |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.1% | 8 | $10 |
| UBS Group AG | 0.00% | Reduce -96.0% | 1 | $1 |
"% of holder's portfolio" is ANEB's weight in each manager's 13F, not the share of Anebulo Pharmaceuticals Inc. the manager owns.